Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan
暂无分享,去创建一个
T. Fujioka | K. Tatsugami | S. Naito | N. Shinohara | A. Matsubara | Y. Kawano | G. Kimura | T. Tsukamoto | K. Mita | Y. Arai | M. Eto | Y. Hirao | S. Hinotsu | K. Hashine